Markus Jahn
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Hematology top 5%
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
Papers in
-
- Iron Metabolism and Disorders 4
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Marc Jennewein (4 shared papers)Dmitry Filosofov (2 shared papers)H. Bihl (2 shared papers)Philip Aschoff (2 shared papers)Konstantin Zhernosekov (2 shared papers)Frank Rösch (1 shared paper)Richard Paul Baum (1 shared paper)A. A. Razbash (1 shared paper)
In The Last Decade
Markus Jahn
15 papers receiving 1.1k citations
Markus Jahn's Hit Papers
Peers
Comparison fields: 5 of 73
- Radiology, Nuclear Medicine and Imaging 449
- Hematology 190
- Biomaterials 110
- Pharmaceutical Science 25
- Drug Discovery 1
Countries citing papers authored by Markus Jahn
This map shows the geographic impact of Markus Jahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Jahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Jahn more than expected).
Fields of papers citing papers by Markus Jahn
This network shows the impact of papers produced by Markus Jahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Jahn. The network helps show where Markus Jahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Jahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Processing of Generator-Produced 68Ga for Medical Application Hit paper breakdown → | 2007 | 441 |
| 2 | 2011 | 225 | |
| 3 | 2009 | 94 | |
| 4 | 2014 | 91 | |
| 5 | 2016 | 55 | |
| 6 | 2005 | 45 | |
| 7 | 2012 | 42 | |
| 8 | 2010 | 36 | |
| 9 | 2017 | 33 | |
| 10 | 2010 | 28 | |
| 11 | 2011 | 17 | |
| 12 | 2007 | 11 | |
| 13 | 2018 | 11 | |
| 14 | 2005 | 7 | |
| 15 | 2020 | 1 |
About Markus Jahn
Markus Jahn is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Analytical Chemistry and Epidemiology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Heat shock proteins research (5 papers), Iron Metabolism and Disorders (4 papers), Analytical Methods in Pharmaceuticals (1 paper), Microfluidic and Capillary Electrophoresis Applications (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (449 citations), Hematology (190 citations), Biomaterials (110 citations), Pharmaceutical Science (25 citations) and Drug Discovery (1 citation). Markus Jahn has collaborated with scholars based in Germany, Russia and Belgium. Frequent co-authors include Marc Jennewein, Dmitry Filosofov, H. Bihl, Philip Aschoff, Konstantin Zhernosekov, Frank Rösch, Richard Paul Baum, A. A. Razbash, Peter Langguth and Matthias Rief. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biomacromolecules, Applied Radiation and Isotopes, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.